Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872466 · ClinicalTrials.gov registry record · NA
Glove Rehabilitation Application for Stroke Patients
A NA study of Virtual Reality and Occupational Therapy, sponsored by Barron Associates.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03872466: Completed NA study of Virtual Reality and Occupational Therapy, sponsored by Barron Associates.
NCT03872466 is a NA study of Virtual Reality and Occupational Therapy that has completed, run by Barron Associates. The registered enrollment target is 21 participants, below the 91-participant average among 19 other Virtual Reality trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03872466, a NA study of Virtual Reality and Occupational Therapy, has completed, sponsored by Barron Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The University of Virginia (UVA) Director of Neurorehabilitation will lead GRASP randomized, controlled efficacy trials. The study will involve employment of the GRASP system in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment.
Primary Outcome
FMUE is one of the most widely used and accepted quantitative measures of motor function in stroke patients, used in clinical and research settings. Individual patient movements associated with specific motor functions are scored using a 3-point ordinal scale (0, 1, or 2). The study employs a subscale of the full assessment that incorporates 33 items relevant to shoulder, elbow, forearm, wrist, hand, and grasp function, thus creating a possible range of 0 to 66 points. Higher scores correspond t
Conditions Studied
Interventions
- DEVICE GRASP HEP
- BEHAVIORAL Usual Care Treatment (UCT)
Study Locations (1)
Virginia
- UVA Outpatient Rehabilitation Clinic - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
What the finished NCT03872466 record still lists
NCT03872466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 91-participant average among 19 other Virtual Reality trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Virtual Reality appearing as the primary indexed condition, and to 2 interventions - of which GRASP HEP is the first listed.
NCT03872466 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03872466 about?
NCT03872466 is a clinical study titled "Glove Rehabilitation Application for Stroke Patients". The University of Virginia (UVA) Director of Neurorehabilitation will lead GRASP randomized, controlled efficacy trials. The study will involve employment of the GRASP system in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment.
What is the current status of trial NCT03872466?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-06-11. Estimated completion is 2022-04-26.
What conditions does trial NCT03872466 study?
This clinical trial studies the following conditions: Virtual Reality, Occupational Therapy.
What interventions are being tested in trial NCT03872466?
The interventions under investigation include: GRASP HEP (DEVICE), Usual Care Treatment (UCT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03872466?
This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03872466 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Virtual Reality
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03872466's enrollment target sits among peer trials
21 16th of 19 higher than 4 of 19 other Virtual Reality trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Virtual Reality trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
The WOW Project (WOW): Wonders Of The World Through Virtual Reality for Hospitalized Children
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers
RECRUITING · NA
-
Virtual Reality During Exercise Testing
RECRUITING · NA
-
Effects of Vestibular Training on Postural Control of Healthy Adults Using Virtual Reality
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI